ABSTRACT
Via antigen-specific ␣␤ T-cell receptors (TCR), T cells respond to peptide fragments of antigen bound to cell-surface major histocompatibility complex (MHC) molecules on antigen-presenting cells (APC) (1, 2) . TCR binding to peptide͞ MHC complexes is aided by CD4 or CD8 coreceptors and leads to T-cell proliferation and differentiation. TCRmediated triggering is generally ineffective, however, unless accompanied by ''costimulatory'' signals (3, 4) . These signals control T-cell production of growth-promoting cytokines such as interleukin 2 (IL-2) and result from interactions between multiple sets of complimentary molecules on T cells and APC-e.g., between CD28 on T cells and B7 on APC. A wide variety of molecules on APC, including B7-1 (5-7), B7-2 (8, 9) , intercellular adhesion molecule 1 (ICAM-1) (10) (11) (12) , and heat stable antigen (13, 14) , are known to express costimulatory function under defined conditions in vitro. Which of these molecules are crucial for costimulation, however, is unclear. This question can be addressed by transfecting cells with genes for known costimulatory molecules and then testing the cells for APC function (15, 16) . A drawback of this approach is that nearly all cell types express at least a low level of certain costimulatory molecules. Such background expression of costimulatory molecules is less of a problem if nonmammalian cells (e.g., Drosophila cells) are used for transfection.
Although Drosophila cells can be stably transfected with mammalian class I molecules (17) , the fact that Drosophila cells die rapidly at 37ЊC makes these cells an unlikely source of APC. In their favor, however, Drosophila cells lack TAP-1,2 peptide transporters, with the result that the class I molecules reaching the cell surface fall apart rapidly unless stabilized with exogenous peptide (18) . This means that class I-transfected Drosophila cells can be induced to express very high levels of specific peptide͞class I complexes-i.e., the ligands for CD8 ϩ T cells.
Using defined peptides as antigen and TCR transgenic T cells as responders, we show here that class I-transfected Drosophila cells are nonimmunogenic for naive CD8 ϩ T cells. When cotransfected with B7-1 and ICAM-1, however, class I-transfected Drosophila cells exhibit potent APC function in the absence of added lymphokines and induce strong proliferative responses, cytokine (IL-2) production, and cytotoxic activity to peptide antigens.
MATERIALS AND METHODS
Mice. 2C TCR transgenic mice were obtained (19) and were bred and maintained in the rodent breeding colony at the Scripps Research Institute.
Cell Lines, Cytokines, and mAbs. The following mAbs were used (20): 3.168 (anti-CD8), RL172 (anti-CD4), J11d (antiheat stable antigen), 28-16-8s (anti-I-A b ), S4B6 (anti-IL-2) (PharMingen), and BVD4-1D11 (anti-IL-4) (PharMingen). The RMA-S.L d cell line and the hybridoma producing the anticlonotypic 1B2 mAb were kindly provided by H. Eisen (Massachusetts Institute of Technology) (21) . Recombinant IL-2 was purchased from Genzyme.
Peptides. Peptides used in this study were synthesized on an Applied Biosystems model 431 A synthesizer. All peptides were purified with C18 reverse-phase HPLC. The concentrations of peptides was determined by quantitative amino acid analysis (22) .
Media. RPMI 1640 medium was supplemented with 10% fetal calf serum (Irvine Scientific), 5% NCTC 109, 2 mM glutamine, 5 ϫ 10 Ϫ5 M 2-mercaptoethanol, and antibiotics (20) .
Generation of Drosophila Cell APC Expressing Murine Class I Molecules and Costimulation Molecules. cDNA encoding B7-1 (23) or ICAM-1 (24) were generated by reverse transcription-PCR of template mRNA from concanavalin A-stimulated spleen cells from BALB͞c mice using oligonucleotides based on the published sequences. These cDNA were fully sequenced and thereafter inserted into the Drosophila expression vector pHMRa-3 containing the metallothionein
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promoter. The generation of pHMRa-3-based expression constructs for L d and murine ␤ 2 -microglobulin has been described (17) . Generation of stable cell lines expressing the various combinations of MHC class I and costimulatory molecules was achieved as follows: 24 g of the appropriate recombinant plasmid DNA (equal amounts of each construct) was transfected together with 1 g of phshneo DNA into Schneider SC2 cells by the calcium phosphate method. Stably transfected cells were selected by culture in Schneiders Drosophila medium containing 8% fetal calf serum (GIBCO͞BRL) and 500 g͞ml geneticin (GIBCO͞BRL). Twenty-four hours before use of the stable cell line, expression of the transfected genes was induced by addition of CuSO 4 to a final concentration of 1 mM.
Purification of CD8 ؉ and CD8 ؊ T Cells. As described previously (25) , cell suspensions prepared from pooled lymph nodes of young adult 2C mice were first treated with a mixture of mAbs (anti-CD4, anti-HSA, anti-I-A b ) plus C (complement) for 45 min at 37ЊC. The surviving cells were further separated into CD8 ϩ cells by panning at 4ЊC for 60-90 min on Petri dishes coated with anti-CD8 mAb.
Proliferation Assay. ϩ 2C cells were cultured with 2 ϫ 10 6 transfected Drosophila cells plus 10 M peptides in a volume of 2 ml in a 24-well culture plate. After 4 days, the cells were pooled and adjusted to the required number. To prepare targets, RMA-S.L d cells were labeled with 51 Cr (100 Ci͞1-2 ϫ 10 6 cells) at 37ЊC for 90 min in the presence or absence of peptides. After labeling, the cells were thoroughly washed and resuspended in medium with or without peptides. Specific 51 Cr release was calculated as described (25) . (21), Red 613-conjugated streptavidin and phycoerythrin-conjugated anti-CD8 mAb (GIBCO͞BRL). Propidium iodide (PI) was included in the last step of staining at 0.5 g͞ml. Live cells (PI negative) were acquired and analyzed on a FACScan using LYSYS software (Becton Dickinson).
RESULTS
Experimental Approach. To test for APC function, Drosophila cells were transfected with a murine class I gene, L d , linked to the metallothionein promoter and then tested for their capacity to present antigen to T cells from the 2C line of transgenic mice (19) . With mouse cells as APC, this line displays strong alloreactivity for L d molecules complexed with an endogenous 8-mer peptide, p2Ca (LSPFPFDL) derived from a Krebs cycle enzyme, 2-oxoglutarate dehydrogenase (OGDH) (26, 27 (22, 28) . A closely related 9-mer peptide, QL9, has even higher affinity for these molecules (2 ϫ 10 8 M Ϫ1 for L d and 2 ϫ 10 7 M Ϫ1 for 2C TCR) (29) . Except for one additional amino acid (glutamine) at the N terminus, QL9 has an identical sequence to p2Ca and, like p2Ca, forms part of the native sequence of OGDH.
With p2Ca and QL9 peptides (prepared in synthetic form) we studied the APC requirements for mature unprimed 2C CD8 ϩ cells in vitro. The responder CD8 ϩ cells were purified from lymph nodes of 2C mice on a C57BL͞6 (B6, H-2 b ) background by mAb plus C treatment followed by positive panning (Materials and Methods); Ͼ95% of the CD8 ϩ cells obtained were clonotype-positive (IB2 ϩ ) and 98% of these cells displayed a naive (CD44 lo ) phenotype. To study APC function, purified CD8 ϩ 2C cells were cultured in the presence of peptides with a panel of
By fluorescence-activated cell sorter (FACS) analysis, cell-surface expression of these molecules on Drosophila cells was moderate ( Fig. 1 ) and no higher than on normal L d (B10.D2) spleen cells (not shown). When cultured at 37ЊC, the viability of Drosophila cells declined to Ͻ1% by 12 hr as measured by PI exclusion. However, most of the cells failed to disintegrate and remained intact for several days.
Early Events. TCR stimulation elicits a complex pattern of intracellular events which lead to early up-regulation of CD25 [IL-2 receptor (IL-2R)] and CD69 on the cell surface (1, 2, 30, 31). These changes are apparent within a few hours of stimulation and are followed by cytokine synthesis and cell proliferation. tions of these peptides are illustrated in Fig. 2b for CD25 expression; near-identical results applied to CD69 expression (not shown).
With L d APC, the stronger QL9 peptide caused a slight increase in CD25 and CD69 expression on 2C T cells, but only at a high concentration of peptide; no increase in the expression of these markers was seen with p2Ca peptide. ϩ cells to either p2Ca or QL9 peptide in the absence of exogenous lymphokines (Fig. 3) . When supplemented with exogenous IL-2 (the ligand for CD25), QL9 peptide induced a significant proliferative response, but only at a high dose of peptide (10 M) (Fig. 3) . Responses elicited by p2Ca peptide, however, were virtually undetectable.
These findings on the effects of adding exogenous IL-2 are thus in close accord with the data on CD25 expression (Fig. 2) . With Drosophila cells as APC, the capacity of signal one alone to cause signs of T-cell activation (up-regulation of CD25 leading to responsiveness to IL-2) was therefore apparent only with a very high affinity peptide (QL9), and then only with a high concentration of this peptide.
The data in Table 1 show day 3 proliferative responses elicited by Drosophila cells in the absence of added lymphokines; peptides were added at a high concentration, 10 M. With the weaker p2Ca peptide, proliferative responses of
ICAM Drosophila APC were undetectable. The lack of proliferation with these APC correlated with a failure to synthesize IL-2 (Table 1) APC, indicating that both molecules had to be expressed on the same cell. Similar synergy between B7 and ICAM applied to the response to the stronger QL9 peptide. With this peptide, however, synergy was more stringent for IL-2 production than for proliferation (but see below for low doses of peptide). Thus, in contrast to p2Ca, QL9 peptide elicited significant proliferative responses with APC expressing either B7 or ICAM.
For p2Ca peptide, optimal proliferative responses elicited by L d .B7.ICAM APC on day 3 required high concentrations of peptide-e.g., 10 M (10 Ϫ5 M) (Fig. 4a) . With QL9 peptide, by contrast, proliferative responses with L d .B7.ICAM APC on day 3 were maximal with 100 nM (10 Ϫ7 M) and were clearly apparent with doses as low as 10 pM (10 Ϫ11 M) (Fig. 4a) . The kinetics of the proliferative response of CD8 ϩ 2C cells to QL9 peptide are shown in Fig. 4 b and B7 .ICAM APC were high on day 3, reached a peak on day 4, and then declined to low levels on day 5 (Fig.  4b) . With a high dose of 10 M (10 Ϫ5 M) QL9, however, the response was low on day 3 but then increased markedly to reach a high peak on day 5 (Fig. 4 b-d) . This prolonged proliferative response was associated with high and sustained production of IL-2 in the cultures (Table 1 and data not shown).
These data applied with the highly immunogenic L d .B7.ICAM APC. With the less immunogenic L d .B7 or L d .ICAM APC, proliferative responses to QL9 peptide reached a peak on day 3-4 (rather than day 5) (Fig. 4c) and required a high dose of peptide (Fig. 4 a and d) (Fig. 4a) . This was in striking contrast to L d .B7.ICAM APC where 1 nM QL9 led to high responses (Ͼ100,000 cpm). Thus, in contrast to the results with high doses of QL9 peptide (Table 1) , the synergistic interaction between B7 and ICAM for proliferative responses became extreme at low peptide doses.
CTL Generation. The capacity of L d .B7, L d .B7.ICAM, and L d .ICAM APC to induce CTL activity to 10 M QL9 peptide in bulk cultures is shown in Fig. 5a ; CTL activity was tested on 51 Cr-labeled RMA.S-L d targets sensitized with p2Ca peptide or an irrelevant peptide (P1A). As expected, strongly immunogenic L d .B7.ICAM APC were highly efficient in generating CTL (Fig. 5a Right). Significantly, L d .B7 APC were also effective in generating CTL (Fig. 5a Left) . The surprising finding, however, was that L d .ICAM APC were totally unable to stimulate CTL generation (Fig. 5a Center) unless stimulated with exogenous IL-2 (Fig. 5b Right) . This finding was unexpected because L d .ICAM APC were no less efficient than L d .B7 APC at inducing proliferative responses (Fig. 4 a, c, and  d) Doses of 5 ϫ 10 4 highly-purified naive-phenotype CD8 ϩ 2C lymph node cells were cultured at 37ЊC with 3 ϫ 10 5 transfected Drosophila cells Ϯ peptides (10 M final concentration) in 0.2 ml in 96-well plates (25) . Proliferative responses were measured by adding [ 3 H]thymidine ( 3 HTdR) (1 Ci͞well) 8 hr before harvest. IL-2 production was measured by removing supernatants from the cultures at 48 hr and adding 50 l supernatant to the IL-2-responsive indicator line, CTLL (25) . Proliferation of the indicator line was measured by addition of [ 3 H]thymidine. It should be noted that Drosophila cells die rapidly at 37ЊC and fail to incorporate 
DISCUSSION
Under physiological conditions, stimulation of naive T cells is controlled by professional APC such as dendritic cells (33) . To define the features of professional APC, we constructed artificial APC from Drosophila cells by gene transfection. Using a TCR transgenic model where the binding affinities involved in TCR͞peptide͞MHC interaction are clearly defined, we show here that class I-transfected Drosophila cells expressing two costimulatory molecules, B7 (B7-1) and ICAM (ICAM-1), act as highly potent APC for naive CD8 ϩ cells. These artificial APC elicit strong IL-2 production, a sustained T-cell-proliferative response and differentiation into effector T cells. In addition, we show that the qualitative features of the primary response of CD8 ϩ cells are influenced by a number of factors, including the concentration of peptide used, the affinity of TCR͞peptide͞MHC interaction, and the particular costimulatory molecules expressed on APC.
The finding that L d -transfected Drosophila cells were nonimmunogenic unless these cells coexpressed costimulatory molecules confirms the crucial importance of costimulation for activating naive T cells (7) . However, the data are difficult to reconcile with a simple two-signal model for T-cell activation. Here, the prevailing view is that signal one (reflecting TCR recognition of MHC͞peptide) leads to partial T-cell activation (e.g., IL-2R expression), whereas signal two (costimulation) elicits cytokine production. In the case of signal one, exposing Another problem with the two-signal model is that, at least for the weaker p2Ca peptide, IL-2 synthesis was virtually undetectable at the protein level unless the APC expressed three different ligands-i.e., L d , B7, and ICAM. The data are thus more compatible with a ''three-signal'' model than a two-signal model (but see below). The marked synergy observed between B7 and ICAM has been reported previously for CD4
ϩ cells and transfected fibroblasts as APC (16) and is shown here to apply to CD8 ϩ cells and to affect three different parameters for T-cell activation, namely IL-2R (and CD69) expression, IL-2 synthesis and proliferation. Although the data are consistent with a three-signal model, it should be stressed that the nature of the synergy between B7 and ICAM is still unclear. In particular, it has yet to be proved that T-cell interaction with B7 and ICAM activates two discrete signaling pathways. In the case of B7, it is well accepted that B7 interaction with CD28 on T cells initiates a distinct signal transduction pathway that synergizes with TCR͞CD3 signals (5) (6) (7) (8) (9) . The situation with ICAM is more complex. Through binding to lymphocyte function-associated antigen 1 (LFA-1) and CD43 counterreceptors on T cells, ICAM is known to facilitate cell adhesion (34, 35) . Hence the ''costimulation'' induced by ICAM may not reflect the induction of a unique signaling pathway but simply enhanced T͞APC interaction leading to more effective TCR͞CD3 crosslinking. Alternatively, ICAM may be bifunctional and induce both signal transduction and enhanced cell adhesion (10, (35) (36) (37) . The data in this paper do not discriminate between these two possibilities.
In the case of L d .ICAM cells, it is of interest that these APC were able to elicit proliferative responses to QL9 peptide but failed to generate CTL unless supplemented with exogenous IL-2. These findings correlated with a failure of L d .ICAM APC to elicit IL-2 production and are in agreement with the evidence from IL-2 Ϫ/Ϫ mice that exposure to IL-2 is not essential for proliferation of CD8 ϩ cells but is obligatory for CTL generation (38) . It is notable that L d .B7 APC generated strong CTL responses even though IL-2 production was apparent only at the level of mRNA. Yet, adding anti-IL-2 mAb ablated CTL generation. The concentration of IL-2 required for CTL production thus appears to be extremely low.
Bearing in mind that Drosophila cells die rapidly at 37ЊC, the capacity of transfected Drosophila cells to act as an extremely potent source of APC for naive CD8 ϩ cells might seem surprising. One has to consider the possibility that Drosophila cells are not a completely neutral vector. Thus one might argue that some of the constitutive surface molecules on Drosophila cells (e.g., carbohydrate moieties) can be recognized by T cells and provide some form of costimulation. Although it is difficult to exclude this possibility, it is striking that peptideinduced up-regulation of IL-2R and CD69 elicited by Drosophila cells expressing L d alone was very limited. This finding implies that the ''background'' level of costimulatory molecules on Drosophila cells must be extremely low.
Despite their rapid loss of viability at 37ЊC, Drosophila cells remained intact for several days and thus presumably continued to display high levels of peptide͞MHC complexes on the cell surface. We attribute the strong APC function of Drosophila cells to the lack of TAP-1,2 peptide transporters in these cells. Because of this deficit, the density of antigen (peptide͞MHC) on the cell surface is very high. TCR stimulation via Signal one is thus intense and, when combined with appropriate costimulation, induces the responding T cells to mount a prolonged proliferative response and strong and sustained production of IL-2. Similar findings apply with professional APC-e.g., with B10.D2 (L d ) dendritic cells (DC). When CD8 ϩ 2C cells respond to B10.D2 DC without exogenous peptide, the low level of endogenous p2Ca and QL9 peptides on these cells stimulates only low IL-2 production and a brief proliferative response (39) . However, augmenting the avidity of T͞APC interaction by adding exogenous QL9 peptide stimulates high IL-2 production and a prolonged proliferative response (39) .
The capacity of Drosophila cells to present a high density of peptide͞MHC complexes suggests that Drosophila cells could be used as APC for normal (nontransgenic) CD8 ϩ cells. In fact, we have found that L d .B7.ICAM APC plus QL9 peptide elicit significant primary responses by normal allogeneic B6 (H-2 b ) CD8 ϩ cells (unpublished data). In addition, transfected Drosophila cells are also capable of inducing normal syngeneic T cells to mount primary proliferative and CTL responses to several different peptides, including tumor-specific peptides (32) . Drosophila cells could thus be a useful tool for tumor immunotherapy.
